World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Keywords:
Novo Nordisk's plans to continue a strategy it has pursued since the founding of the two original companies in the 1920's, of focussing on diabetes treatment worldwide and not pursuing major merger or acquisition deals. Novo Nordisk will pursue a strategy of increasing R&D hiring by 3000, hiring 6000 new employees by 2022. Novo Nordisk has market caitalization of $120 billion and is the largest Nordic company. With the increasing number of diabetes population Novo Nordisk is growing at 12% a year. Novo Nordisk Foundation has 74% of the voting rights and 25.5% of voting capital in the company.
Denmark's pharmaceutical maker Novo Nordisk strategies
02/12/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Wall Street Journal 02/12/2013
Novo Nordisk management
02/12/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Wall Street Journal 02/12/2013
Novo Nordisk's Tresiba drug for diabetes
02/12/2013
Grouped Articles
Wall Street Journal 02/12/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Novo Nordisk and increasing competition in the diabetes market
08/25/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Novo Nordisk performance
02/12/2013
Grouped Articles
Rivals Threaten to Crowd Out Novo in Expanding Diabetes Market
Wall Street Journal 08/25/2013
Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
Wall Street Journal 06/17/2014
Novo Nordisk's Comeback Needs Nods From Regulators
Wall Street Journal 09/03/2014
Novo Nordisk’s Insulin Move Is Right Medicine
Wall Street Journal 03/29/2015
Wall Street Journal 02/12/2013
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us